150 related articles for article (PubMed ID: 23648299)
21. Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer.
Jang J; Kim HK; Cho BC; Lee KH; Yun HJ; Woo IS; Song HS; Ryoo HM; Kim CH; Sun DS; Shin JW
Cancer Chemother Pharmacol; 2017 May; 79(5):873-880. PubMed ID: 28341958
[TBL] [Abstract][Full Text] [Related]
22. Docetaxel followed by gemcitabine in the treatment of advanced non-small cell lung cancer: a phase I study.
Frassineti GL; Ibrahim T; Zoli W; Monti M; Ricotti L; Nanni O; Amadori D
Tumori; 2002; 88(2):99-103. PubMed ID: 12088266
[TBL] [Abstract][Full Text] [Related]
23. [Phase I study of gemcitabine hydrochloride (LY 188011) combination therapy with cisplatin in the patients with non-small cell lung cancer].
Kurita Y; Yokoyama A; Matsui K; Hara N; Nakai Y; Ohhashi Y; Niitani H
Gan To Kagaku Ryoho; 1999 Jun; 26(7):898-907. PubMed ID: 10396316
[TBL] [Abstract][Full Text] [Related]
24. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
[TBL] [Abstract][Full Text] [Related]
25. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Billings FT; Bradof JE; Baker M; Greco FA
Cancer; 2001 Nov; 92(9):2391-8. PubMed ID: 11745295
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.
Rodriguez J; Cortes J; Calvo E; Azinovic I; Fernandez-Hildago O; Martinez-Monge R; Garzon C; de Irala J; Martinez-Aguillo M; Ramon Y Cajal T; Brugarolas A
Cancer; 2000 Dec; 89(12):2622-9. PubMed ID: 11135224
[TBL] [Abstract][Full Text] [Related]
27. A phase I/II study comparing regimen schedules of gemcitabine and docetaxel in Japanese patients with stage IIIB/IV non-small cell lung cancer.
Matsui K; Hirashima T; Nitta T; Kobayashi M; Ogata Y; Furukawa M; Kudoh S; Yoshimura N; Mukohara T; Yamauchi S; Shiraishi S; Kamoi H; Negoro S; Takeda K; Nakagawa K; Takada M; Yana T; Fukuoka M
Jpn J Clin Oncol; 2005 Apr; 35(4):181-7. PubMed ID: 15845566
[TBL] [Abstract][Full Text] [Related]
28. Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study.
Nishimoto K; Karayama M; Inui N; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inami N; Matsuura S; Kaida Y; Matsui T; Asada K; Matsuda H; Fujii M; Toyoshima M; Imokawa S; Suda T
Med Oncol; 2018 Jun; 35(7):108. PubMed ID: 29909581
[TBL] [Abstract][Full Text] [Related]
29. [Chemotherapy of the elderly patients with advanced non-small cell lung cancer].
Cheng ZW; Zhang L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):330-4. PubMed ID: 15266841
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis.
Li J; Chen R; Ji M; Zou SL; Zhu LN
Cancer Chemother Pharmacol; 2015 Sep; 76(3):651-5. PubMed ID: 26093951
[TBL] [Abstract][Full Text] [Related]
31. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma.
Abratt RP; Hacking DJ; Goedhals L; Bezwoda WR
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-18-S8-23. PubMed ID: 9207311
[TBL] [Abstract][Full Text] [Related]
32. Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience.
Tada H; Matsui S; Kawahara M; Hosoe S; Hamada C; Fukushima M
Eur J Cancer Care (Engl); 2008 Mar; 17(2):120-6. PubMed ID: 18302648
[TBL] [Abstract][Full Text] [Related]
33. Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling.
Huisman C; Giaccone G; van Groeningen CJ; Sutedja G; Postmus PE; Smit EF
Lung Cancer; 2001; 33(2-3):267-75. PubMed ID: 11551422
[TBL] [Abstract][Full Text] [Related]
34. An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
Pectasides D; Kalofonos HP; Samantas E; Nicolaides C; Papacostas P; Onyenadum A; Visvikis A; Skarlos D; Fountzilas G
Anticancer Res; 2001; 21(4B):3005-10. PubMed ID: 11712802
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer.
Kim DY; Lee KW; Yun T; Kim DW; Kim TY; Heo DS; Bang YJ; Kim NK
Oncol Rep; 2005 Jul; 14(1):207-11. PubMed ID: 15944791
[TBL] [Abstract][Full Text] [Related]
36. Special patients, special treatments.
Spiridonidis CH
Clin Lung Cancer; 2003 Jul; 5(1):39. PubMed ID: 14596702
[No Abstract] [Full Text] [Related]
37. First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly 'unfrail' patients with advanced non-small-cell lung cancer: a multicenter phase II study.
Tibaldi C; Camerini A; D'Incecco A; Vasile E; Fabbri A; Amoroso D; Cappuzzo F
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2003-8. PubMed ID: 22767317
[TBL] [Abstract][Full Text] [Related]
38. Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer.
Iwasaki Y; Ohsugi S; Natsuhara A; Tsubokura T; Harada H; Ueda M; Arimoto T; Hara H; Yamada T; Takesako T; Kohno K; Hosogi S; Nakanishi M; Marunaka Y; Nishimura T
Cancer Chemother Pharmacol; 2006 Dec; 58(6):735-41. PubMed ID: 16565832
[TBL] [Abstract][Full Text] [Related]
39. A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study.
Rossi D; Graziano F; Catalano V; Giordani P; Fedeli SL; Alessandroni P; Fedeli A; Dennetta D; Ugolini M; Catalano G
Anticancer Res; 2002; 22(5):3087-92. PubMed ID: 12530048
[TBL] [Abstract][Full Text] [Related]
40. Challenging the platinum combinations in the chemotherapy of NSCLC.
Douillard JY; Eckardt J; Scagliotti GV
Lung Cancer; 2002 Dec; 38 Suppl 4():21-8. PubMed ID: 12480191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
